Douglas Onsi is the founder of Leap Therapeutics. Leap Therapeutics has raised $99M in total funding. Latest round: Series B. Backed by Winklevoss Capital.
Douglas E. Onsi is the President and Chief Executive Officer of Leap Therapeutics, a biopharmaceutical company focused on developing precision medicine for cancer patients. He previously served as Chief Financial Officer at the company before assuming the CEO role.
Full founder directory · Investor directory · Company funding database · Fundraising library